Drugmakers Get Updated Tips on Spotting Fake, Tainted Products

The FDA plans to request that supply chain entities in possession of a suspect drug product help verify whether it’s counterfeit or potentially tainted, the agency said in draft guidance.

The agency on Wednesday released revisions to 2018 guidelines on verification systems that drugmakers, wholesale distributors, dispensers, and repackagers must have in place for identifying and isolating illegitimate drugs. The recommendations are meant to help the FDA better trace and validate prescription drugs that may be fake, stolen, or altered in a way that could have adverse health effects for patients.

The draft guidance aims to help entities comply ...